ZURICH, April 2 (Reuters) – Novartis took its campaign to invigorate sluggish sales of its new heart-failure medicine Entresto to a U.S. cardiologists meeting on Saturday, telling attendees that even…
The post Novartis takes Entresto case to U.S. cardiologist meeting appeared first on NASDAQ.